Clinical Trial Update: Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Bayesian dose adjustment of immunosuppressants in lung and heart-lung transplant patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart-lung Transplantation
• Lung Transplantation

Drugs mentioned

• Immunosuppressants

Snippet

Sponsor: University Hospital, Limoges | Conditions: Lung and Heart-lung Transplantation | Phase 4 | Status: TERMINATED